Market Overview The China Life Science Analytics Market is experiencing explosive growth driven by evolving regulatory frameworks, clinical trial optimization needs, and compliance technology demand. The market reached USD 1,231.2 million in 2024 and is projected to grow at an 11.1% CAGR to USD 3,918.5 million by 2035. Regulatory compliance applications are expanding as authorities streamline...